Brokerages expect that Option Care Health (NASDAQ:OPCH) will post earnings of ($0.03) per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Option Care Health’s earnings, with the lowest EPS estimate coming in at ($0.05) and the highest estimate coming in at $0.02. Option Care Health posted earnings of ($0.04) per share during the same quarter last year, which would indicate a positive year over year growth rate of 25%. The firm is expected to issue its next earnings report on Wednesday, November 4th.
On average, analysts expect that Option Care Health will report full year earnings of ($0.17) per share for the current fiscal year, with EPS estimates ranging from ($0.19) to ($0.16). For the next year, analysts anticipate that the firm will post earnings of $0.17 per share, with EPS estimates ranging from $0.00 to $0.29. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover Option Care Health.
Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, August 4th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). Option Care Health had a negative return on equity of 4.05% and a negative net margin of 3.10%. The company had revenue of $740.80 million for the quarter, compared to analyst estimates of $740.80 million. During the same quarter in the prior year, the company earned ($0.14) EPS. The firm’s revenue for the quarter was up 49.0% compared to the same quarter last year.
Several equities research analysts recently weighed in on OPCH shares. SunTrust Banks lifted their price objective on Option Care Health from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Bank of America started coverage on shares of Option Care Health in a report on Wednesday, June 24th. They issued a “buy” rating and a $18.00 price objective for the company. Barrington Research lifted their price objective on shares of Option Care Health from $17.00 to $19.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Finally, Zacks Investment Research raised Option Care Health from a “hold” rating to a “buy” rating and set a $14.00 target price for the company in a report on Thursday, August 6th. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $19.17.
OPCH stock traded up $0.23 during trading on Friday, reaching $11.20. The stock had a trading volume of 8,040 shares, compared to its average volume of 494,152. The company’s 50 day moving average is $11.69 and its two-hundred day moving average is $12.46. The company has a quick ratio of 1.24, a current ratio of 1.62 and a debt-to-equity ratio of 1.47. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of -21.73 and a beta of 1.20. Option Care Health has a one year low of $5.74 and a one year high of $18.21.
In related news, Director Timothy P. Sullivan sold 2,700,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $12.50, for a total value of $33,750,000.00. Following the sale, the director now owns 32,690 shares in the company, valued at $408,625. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy P. Sullivan sold 8,000,000 shares of the firm’s stock in a transaction dated Friday, July 24th. The stock was sold at an average price of $12.50, for a total value of $100,000,000.00. Following the completion of the transaction, the director now directly owns 32,690 shares in the company, valued at $408,625. The disclosure for this sale can be found here. 80.90% of the stock is owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Great West Life Assurance Co. Can purchased a new position in shares of Option Care Health during the 2nd quarter valued at about $31,000. Bank of Montreal Can bought a new position in shares of Option Care Health during the 2nd quarter valued at approximately $32,000. Victory Capital Management Inc. bought a new position in shares of Option Care Health during the 1st quarter valued at approximately $55,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Option Care Health during the 1st quarter valued at approximately $57,000. Finally, Legal & General Group Plc bought a new position in shares of Option Care Health during the 1st quarter valued at approximately $64,000. Institutional investors and hedge funds own 14.22% of the company’s stock.
About Option Care Health
Option Care Health, Inc provides independent home and alternate site infusion services in the United States. It serves patients with acute and chronic conditions. The company is based in Bannockburn, Illinois.
Further Reading: What is the Ex-Dividend Date in Investing?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.